Eric J Haas
Overview
Explore the profile of Eric J Haas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
2083
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Orth A, Curran E, Haas E, Kraemer A, Anderson A, Mason N, et al.
Insects
. 2022 Mar;
13(3).
PMID: 35323537
Honey bee propolis is a complex, resinous mixture created by bees using plant sources such as leaves, flowers, and bud exudates. This study characterized how cropland surrounding apiaries affects the...
2.
Singer S, Angulo F, Swerdlow D, McLaughlin J, Hazan I, Ginish N, et al.
EClinicalMedicine
. 2021 Dec;
42:101190.
PMID: 34870134
Background: SARS-CoV-2 variant Beta (B.1.351) was designated as a Variant of Concern (VoC) after becoming the dominant strain in South Africa and spreading internationally. BNT162b2 showed lower levels of neutralizing...
3.
Goldberg Y, Mandel M, Bar-On Y, Bodenheimer O, Freedman L, Haas E, et al.
N Engl J Med
. 2021 Oct;
385(24):e85.
PMID: 34706170
Background: In December 2020, Israel began a mass vaccination campaign against coronavirus disease 2019 (Covid-19) by administering the BNT162b2 vaccine, which led to a sharp curtailing of the outbreak. After...
4.
Anis E, Haas E, Indenbaum V, Singer S, Warshavsky B, Rishpon S, et al.
J Infect
. 2021 Oct;
83(6):678-685.
PMID: 34626701
No abstract available.
5.
Mevorach D, Anis E, Cedar N, Bromberg M, Haas E, Nadir E, et al.
N Engl J Med
. 2021 Oct;
385(23):2140-2149.
PMID: 34614328
Background: Approximately 5.1 million Israelis had been fully immunized against coronavirus disease 2019 (Covid-19) after receiving two doses of the BNT162b2 messenger RNA vaccine (Pfizer-BioNTech) by May 31, 2021. After...
6.
Haas E, McLaughlin J, Khan F, Angulo F, Anis E, Lipsitch M, et al.
Lancet Infect Dis
. 2021 Sep;
22(3):357-366.
PMID: 34562375
Background: On Dec 20, 2020, Israel initiated a nationwide COVID-19 vaccination campaign for people aged 16 years and older and exclusively used the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine (tozinameran). We...
7.
Kerub O, Rosenthal A, Haas E, Meiri G, Menashe I, Davidovitch N
Health Soc Care Community
. 2021 Jun;
30(4):1391-1399.
PMID: 34080739
Early autism spectrum disorder (ASD) detection is a precondition for effective intervention and facilitates significant improvements in functioning. In Israel, toddlers undergo general developmental screening by public health nurses (PHNs)...
8.
Haas E, Angulo F, McLaughlin J, Anis E, Singer S, Khan F, et al.
Lancet
. 2021 May;
397(10287):1819-1829.
PMID: 33964222
Background: Following the emergency use authorisation of the Pfizer-BioNTech mRNA COVID-19 vaccine BNT162b2 (international non-proprietary name tozinameran) in Israel, the Ministry of Health (MoH) launched a campaign to immunise the...
9.
Kerub O, Haas E, Meiri G, Bilenko N, Flusser H, Michaelovski A, et al.
Autism Res
. 2020 Oct;
14(1):193-201.
PMID: 33078561
The prevalence of autism spectrum disorder (ASD) is continuously rising worldwide, with remarkable differences in ASD rates being reported across ethnic and socioeconomic groups. We conducted a prospective cohort study...
10.
Langsam D, Anis E, Haas E, Gosinov R, Yechezkel M, Grotto I, et al.
Vaccine
. 2020 Feb;
38(12):2700-2706.
PMID: 32070682
Pertussis incidence in developed countries, including Israel, has increased over the past two decades despite the addition of two booster doses in children. However, as pertussis is characterized by a...